Aim. Red cell distribution width (RDW) is a measure of anisocytosis. Higher values are robustly associated to adverse outcome in several conditions, including chronic heart failure (HF). The present study aimed to compared its prognostic role with that of echocardiographic parameters in this kind of patients.
Introduction
Red cell distribution width (RDW) is a measure of erythrocytes size variability (anisocytosis); in particular it represents the coefficient of Original Article and RDW. In particular, RDW was promptly measured (within 5 minutes) after blood collection with the use of the Coulter LH 780 analyzer (Beckman Coulter Inc., FL) at our hospital laboratory. Glomerular filtration rate was estimated (eGFR) according to Cockroft and Gault's formula.
Statistical analysis
Continue variables were expressed as mean ± standard deviation (SD) while categorical ones as frequency (n) and percentage of the sample. Continue variables were visually tested to confirm a normal distribution by Q-Q plots and then compared by unpaired samples Student's t test, while categorical ones with χ 2 test and Fisher's exact test if dichotomic. For RDW a receiver-operating characteristic (ROC) curve was created regarding adverse outcome, and a cut-off with both best specificity and sensitivity was chosen (resulting 14.45%). Univariate analysis including proportion of RDW>14.45% and those parameters which correlated to the outcome was elaborated to investigate which of them remained statistically significant respect of the outcome. Multivariate logistic regression was run to calculate odds ratios (ORs) together with their 95% confidence intervals (CIs) for proportion of RDW>14.45% and those variables that significantly correlated to the outcome, in order to analyze their ability to predict the outcome. Finally, ROC curves were used to determine the predictiveness of cardiovascular death or HF hospitalization for the parameters that resulted statistically correlated with adverse outcome; area under ROC curves (AUROCs) and their CIs were also calculated. In this case we obviously used RDW as a continuous variable. P values less than 0.05 were considered statistically significant. Data were analyzed using SPSS statistical package for Windows (Version 20.0; SPSS, Inc., Chicago, IL, USA).
Results
During one-year follow-up we found 3 cases of death (1.3%) and 46 hospitalizations (19.8%), while 183 subjects (78.9%) did not experience the study primary endpoint. Demographic, clinical, and echocardiographic characteristics are listed in Table 1 ; they are reported for the whole population and for the two groups according to follow-up events. People who died or were hospitalized significantly differed with those who experienced positive outcome respect of age (older), sex (female), diabetes mellitus, NYHA functional class (worse), eGFR (reduced), LVEF (lower), LVEDD index (greater), PWT (thicker), LV mass index (heavier), mitral regurgitation grade (worse), left atrial volume (larger), E/A ratio (more altered), and RDW (bigger). Interestingly, heamoglobin value did not significantly differ between the two groups (p=0.084), albeit being reduced in those who experienced the study primary endpoint. ROC curve for RDW suggested 14.45% as best cut-off value, with a sensibility of 76% and a specificity of 64% (Table  2) . Moreover, we carried out an univariate analysis including RDW>14.45% and parameters correlated to the study primary endpoint, demonstrating that LVEF, PWT, LV mass index, mitral regurgitation grade, and RDW>14.45% still remained associated to the study primary endpoint, even adjusting for other considered parameters (Table 3 ). In the same way, we ran a multivariate logistic regression with the same parameters; LVEF, PWT, and RDW>14.45% significantly predicted the study primary endpoint, even taken together (Table 4) . In particular, patients with RDW value above 14.45% had 3.894 times (95% CI: 1.042-14.555) the risk of cardiovascular death and/or HF hospitalization than those with RDW below or equal to that cut-off. Finally, the study primary endpoint-related ROC curves parameters of NYHA functional class, LVEF, PWT, LV mass index, age, mitral regurgitation grade, eGFR, left atrial volume, E/A ratio, LVEDD, and RDW>14.45% variation of the red cell mean corpuscular volume (MCV) and its normal values range from 12 to 17% [1] . Typically, RDW increases in haemolytic diseases, conditions causing reticulocytosis, thrombotic thrombocytopenic purpura, inflammatory bowel diseases, and pregnancy [2] [3] [4] [5] [6] . However, recently, RDW has been found a good predictor marker for heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) (CHARM study) [7] , with preserved LVEF [8] , and for subject with prior myocardial infarction without HF (CARE study) [9] . Although these and other demonstrations [10] [11] [12] [13] [14] , including a meta-analysis [15] , no studies to our knowledge have yet investigated the predictive ability of RDW compared to traditionally evaluated echocardiographic parameters in chronic HF patients. We thus sought to examine this aspect in order to find how useful could routine RDW assessment be in this kind of subjects.
Methods

Subjects
From September 2012 to September 2013 we consecutively enrolled 232 stable and optimally treated patients affected by chronic HF and followed by the Heart Failure Center of the Cardiologic Unit of University Civil Hospital of Brescia, Italy. Inclusion criteria were: patients with clinically stable HF caused by LV systolic dysfunction (defined by LVEF <45% or LV end-diastolic diameter (LVEDD) ≥32 mm/m 2 in sinus rhythm) with at least one hospitalization for HF in the previous year, ischaemic or idiopathic aetiology. We excluded patients with: primary valve heart diseases or congenital heart diseases; recent (<3 months) unstable angina or acute myocardial infarction. By enrolment, patients had been clinically evaluated with 12-derivative electrocardiography (ECG), Doppler echocardiography, and blood sampling. The primary endpoint of the study was cardiovascular death and/or HF hospitalization in the first year after enrolment. We state that our study complies with the Declaration of Helsinki; Ethical Committee approval was waived because of the retrospective analysis of the study according to the national law regulating observational retrospective studies (law no. 11960, released on 13 July, 2004). However, all patients gave their informed consent to access their data for scientific purposes.
Echocardiography
Echocardiographic examinations were performed using Vivid 7 machine (GE Healthcare, Milwaukee, SI, USA) with a 3.5 MHz transducer. Digital loops were stored on the hard disk of the echocardiograph for on-line and off-line analyses and transferred to a workstation EchoPac, Vingmed (GE Healthcare) for off-line analysis. Participants were studied in the left lateral decubitus position and images acquired from standard parasternal and apical windows. All studies were read by two echocardiographists blinded to all patient informations. The echocardiographic measurements of the left ventricular internal dimension, peak E wave and A wave of mitral inflow, left atrial size were performed off-line, according to recommendations of the American Society of Echocardiography [16, 17] . LV volumes and ejection fraction were obtained by the modified biplane Simpson method. LV mass was calculated according to the formula: 0.8 x [1.04 x (LVEDD+ PWT + SWT) 3 -(LVEDD) 3 )] + 0.6 (g), in which PWT is posterior wall thickness, and SWT septal wall thickness, all measured in cm.
Laboratory analysis
Blood was sampled for the measurement of routine chemistry including total cholesterol, triglycerides, creatinine, heamoglobin, MCV are represented in Table 2 , revealing that the best predictor of cardiovascular death or HF hospitalization after LVEF and NYHA functional class was RDW>14.45%.
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Discussion
In the present study we found that: 1) RDW is a better predictor of cardiovascular death and/or HF hospitalization in HF patients than several echocardiographic parameters associated to outcome itself (LV mass index, mitral regurgitation grade); 2) RDW predicts HF prognosis even adjusting for echocardiographic parameters, age and NYHA functional class.
First of all we pinpoint that the subjects in this study did not suffer from haemolytic conditions, known bone marrow dysfunction, chronic inflammatory diseases, renal, thyroid, hepatic pathologies, had not iron, folic acid, or vitamin B12 deficiency (as shown by MCV value), nor received blood transfusions. In fact, the cited conditions are responsible of RDW alterations which can be potential confounders regarding HF prognosis. Moreover, RDW may also reflect ethnicity, neurohumoral activation, and use of any medications, parameters reasonably homogeneous in our population [18] . On the other hand the study primary Original Article endpoint group had a significantly reduced eGFR. In addition, every effort was made to analyze as quickly as possible (within 5 minutes) blood samples because longer processing time can cause abnormal results in RDW evaluation. Of note, RDW predictive capability was not associated to anaemia in our population, which is another prognostic factor for HF [19] . In addition, parameters widely associated with adverse prognosis are not associated to it in this study (i.e., diabetes mellitus, eGFR, diastolic dysfunction, mitral regurgitation grade, left atrial volume, etc.). We hypothesized that our patients were too much homogeneous and our population too small to allow these parameters catching a difference regarding the study primary endpoint. LVEF and functional capacity according to NYHA are the two most important parameters evaluated in HF. In our study RDW resulted slightly less predictive than them (AUROC 0.761 vs. 0.808 or 0.762, respectively). Moreover, the correlation between RDW and both LVEF and NYHA class was found strongly significant. This result confirms those of previous studies [7, [10] [11] [12] [13] [14] [15] . Despite this, we hereby first suggested that RDW assessment in stable and closely followed-up chronic HF patients is more useful than mitral regurgitation grade, LV mass index, PWT, LVEDD, left atrial size, and E/A ratio. Even adjusting for them, RDW maintained its prognostic role. In addition, RDW is present in any standard complete blood count and is clearly less expensive and easier to obtain than echocardiographic examination, suggesting that it could be a very useful tool in every clinical setting.
RDW is a statistical parameter whose role in HF is still difficult to understand. Three recent studies demonstrated that its value in this context is independent of anaemia [14, 20, 21] . Förhécz et al., in fact, suggested that RDW is nonspecifically associated to iron deficiency, inflammation, ineffective erythropoiesis, malnutrition, neurohormonal activation, and renal impairment, which are all linked to worsening HF [22] .
There are potential limitations of this study. First, we did not evaluate inflammation markers, NT-proBNP, neurohormonal parameters (renin, angiotensin II, epinephrine). Second, we did not directly measure vitamin B12 and folic acid; nevertheless our population is at least only slightly anaemic and this aspect could be negligible.
Conclusions
This study confirms the prognostic role of RDW in chronic HF and may contribute to expand our tool bag in order to better follow-up these patients. Further studies are needed to understand the true significance of RDW increasing in chronic HF subjects. pime pime pime pime p pi im me e EDITRICE Table 2 . Area under receiver-operating characteristic (AUROC) curves for parameters statistically significant in Table 1 
